Clinical Trials Browser

Phase 2 × Hormone Refractory Prostate Cancer × Sunitinib × Clear all

NCT00795171 2010-08-18

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Phase 2 Unknown

Hormone Refractory Prostate Cancer